73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Cellular 'waste product' rejuvenates cancer-fighting immune cells

Cellular 'waste product' rejuvenates cancer-fighting immune cells

byUT Southwestern Medical CenterUT Southwestern Simmons Cancer Center found that lactate, a metabolic byproduct produced by cells during strenuous exercise, can rejuvenate immune cells that figh

Cellular 'waste product' rejuvenates cancer-fighting immune cells

byUT Southwestern Medical CenterUT Southwestern Simmons Cancer Center found that lactate, a metabolic byproduct produced by cells during strenuous exercise, can rejuvenate immune cells that figh
Small-Volume Blood Collection Tubes Can Reduce Transfusions in Intensive Care

Small-Volume Blood Collection Tubes Can Reduce Transfusions in Intensive Care

January 2024Leah LawrenceNew data indicate that the use of tubes that automatically collect less blood in the intensive care unit (ICU) may decrease red blood cell (RBC) transfusions without affecting

Small-Volume Blood Collection Tubes Can Reduce Transfusions in Intensive Care

January 2024Leah LawrenceNew data indicate that the use of tubes that automatically collect less blood in the intensive care unit (ICU) may decrease red blood cell (RBC) transfusions without affecting
RNA thought to spread cancer shows ability to suppress breast cancer metastasis

RNA thought to spread cancer shows ability to suppress breast cancer metastasis

byUniversity of Texas M. D. Anderson Cancer CenterLi Ma, Ph.D. Credit: MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RN

RNA thought to spread cancer shows ability to suppress breast cancer metastasis

byUniversity of Texas M. D. Anderson Cancer CenterLi Ma, Ph.D. Credit: MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer Center have discovered that a form of RN
How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha
Boosting immunotherapy in non-responsive cancer cells

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca
Gene and cell therapies to combat pancreatic cancer

Gene and cell therapies to combat pancreatic cancer

byMary Ann Liebert, IncGTMP clinical trials for pancreatic cancer depending on phase and trial status. Source: Clinical trial.gov. GTMPs, gene therapy medicinal products. Credit:Human Gene

Gene and cell therapies to combat pancreatic cancer

byMary Ann Liebert, IncGTMP clinical trials for pancreatic cancer depending on phase and trial status. Source: Clinical trial.gov. GTMPs, gene therapy medicinal products. Credit:Human Gene
Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance
Exploring artificial general intelligence for radiation oncology

Exploring artificial general intelligence for radiation oncology

by KeAi Communications Co.Large Multimodal Foundation Models For Radiation Oncology. Credit: Chenbin LiuAn estimated 600,000 people in the United States succumb to cancer every year. Beyond surgery, c

Exploring artificial general intelligence for radiation oncology

by KeAi Communications Co.Large Multimodal Foundation Models For Radiation Oncology. Credit: Chenbin LiuAn estimated 600,000 people in the United States succumb to cancer every year. Beyond surgery, c
Most incidentally found adrenal tumors are nonfunctioning, regardless of patient age

Most incidentally found adrenal tumors are nonfunctioning, regardless of patient age

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an uns

Most incidentally found adrenal tumors are nonfunctioning, regardless of patient age

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an uns
Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

by Impact Journals LLCHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Anew review papertitled "Current perspect

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

by Impact Journals LLCHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Anew review papertitled "Current perspect
Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in